DnB Asset Management
AERI

DnB Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

DnB Asset Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,129
Closed -$253K – 657
2021
Q1 		$253K Sell
14,129
-90,073
-86% -$1.56M ﹤0.01% 632
2020
Q4 		$1.41M Buy
+104,202
New +$1.26M 0.01% 522

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DnB Asset Management's AERI Position: Q2 2021 in Review

DnB Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 14,129 shares — an estimated $253K sold.

DnB Asset Management first reported a position in AERI in Q4 2020 and held it in 2 quarters. The position peaked at $1.41M in Q4 2020. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

  • DnB Asset Management reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • DnB Asset Management sold 14,129 Aerie Pharmaceuticals shares in Q2 2021, an estimated $253K.
  • DnB Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • DnB Asset Management's Aerie Pharmaceuticals position peaked at $1.41M in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on DnB Asset Management's 13F filing for Q2 2021, filed 6 Jul 2021.